Status of branched endovascular aortic arch repair.
Multiple medical device manufacturers are developing branched endografts for thoracic endovascular aortic repair (TEVAR), to provide a minimally invasive alternative for the treatment of aortic arch pathologies in patients who are deemed unfit for open or hybrid arch repair. Different branched endografts have been introduced, with varying number, size and orientation of the branches that redirect flow to the supra-aortic arteries. We present an overview of the currently investigated devices and review their outcomes. The results of branched TEVAR are promising, yet stroke remains the predominant periprocedural concern. For now, these procedures should be limited to select expert centers where the design and deployment procedure of branched endografts can be further developed to reduce the risk of stroke.
['van Bakel|Theodorus M|TM|', 'de Beaufort|Hector W|HW|', 'Trimarchi|Santi|S|', 'Marrocco-Trischitta|Massimiliano M|MM|', 'Bismuth|Jean|J|', 'Moll|Frans L|FL|', 'Patel|Himanshu J|HJ|', 'van Herwaarden|Joost A|JA|']
aortic arch repair Thoracic endovascular aortic repair (TEVAR) branched TEVAR stent graft design